BAPI President, Mr. Nazmul Hassan MP’s Interview on CNN
Welcome on BAPI website
Who are we?
History of BAPI
Bangladesh Association of Pharmaceutical Industries (BAPI) is the apex body representing the pharmaceutical companies of Bangladesh. Since its inception in 1972, BAPI has been playing a key role in developing the pharma sector in the country to promote access to affordable drugs. Closely working with the industry and regulatory authorities, the association promotes understanding of good manufacturing practices (GMP), and rightful implementation to ensure quality of the medicines.
Read moreRole of BAPI
- Since its inception in 1972, BAPI has been playing a key role in developing the pharma sector in the country to promote access to affordable drugs.
- Closely working with the industry and regulatory authorities, the association promotes understanding of good manufacturing practices (GMP), and rightful implementation to ensure quality of the medicines.
BAPI at a Glance
Today, Bangladesh has fulfilled another “National Aspiration” of “Turning an Import based Pharmaceutical Industry into an exporter of quality medicines”
Overview
Global Footprint
We are expanding our Global Footprint
Export is growing fast, the current export earning is more than $169.02 Mn (crossing the mark of BDT 14 Bn)
Bangladesh Government has declared Pharmaceuticals as the “Thrust Sector”
Approximately 1200 pharmaceutical products received registration for export over the last two years and are being exported to more than 150 countries including USA, UK, Canada, Australia, Germany, EU etc.
Prospect & opportunities
Competitive edge of Bangladesh Pharma
Global generics market is valued at around US $1.06 Tn and is projected to grow $1.30 Tn by 2020
Generic drugs will continue to grow maintaining healthy rate
Drugs worth more than $200 Bn coming off patent by 2025
Rising healthcare cost, particularly cost of medicine has become a global concern
API Park
Brief Outline
Plant Layout
- Total land area: 81 Hectares (200 acres)
- Overall project cost $30 million
- Plot handed over within 2018
- Local companies have already lined up with some US $300 million for investment for setting up facilities
About Bangladesh
Events
-
Asia Pharma Expo 2017
Read more...
Bangladesh Association of Pharmaceutical Industries (Bangladesh Aushad Shilpa Samity) feels pleasure to announce the 9th Asia Pharma Expo 2017 (APE 2017),
-
Asia Pharma Expo 2016
Read more...
Since 2003, BAPI has been successfully organizing the Asia Pharma Expo till this date. BAPI organized the 8th Asia Pharma Expo 2016 on the 28th, 29th and 30th January 2016.
-
45th Annual General Meeting 2016: Pharma sector to cash in on patent exemption
Read more...
The Bangladesh Association of Pharmaceutical Industries (BAPI) aims to make the country's pharmaceutical industry a multi-billion dollar sector. This was discussed at the 45th annual general meeting of BAPI at a city hotel yesterday. Following the meeting, a program was held at the same venue to discuss “Vision 2033” for the pharmaceutical industry.
Latest News
-
Inauguration of Incepta Vaccine Bulk Manufacturing Facility; a Journey to be a Self-sufficient Vaccine Manufacturing Country
Incepta Vaccine Ltd has launched its vaccine bulk manufacturing facility in Savar, Dhaka. Honorable health Minister Mohammed Nasim, MP inaugurated the facility on Thursday, 28 July 2016.
-
New Executive Committee of BAPI
In the 45th Annual General Meeting of BAPI the new executive committee was declared as:
Read more... -
Beximco Pharma commences export to the United States
First Bangladeshi pharmaceutical company to launch pharmaceutical products in the US Beximco Pharmaceuticals Limited (“BPL”, “Beximco Pharma” or “Company”; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces it has commenced the export of Carvedilol,
Read more...
